Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods to treat mucopolysaccharide type I or deficiency in alpha-L-iduronidase using a recombinant adeno-associated virus encoding alpha-L-iduronidase

Methods to treat mucopolysaccharide type I or deficiency in alpha-L-iduronidase using a recombinant adeno-associated virus encoding alpha-L-iduronidase

US Patent 9827295 · Granted Nov 28, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods to treat mucopolysaccharidosis type II or deficiency in iduronate-2-sulf2024
Methods to treat mucopolysaccharidosis type II or deficiency in iduronate-2-sulf2024
Methods to treat mucopolysaccharidosis type II or deficiency in iduronate-2-sulf2024
Methods to treat mucopolysaccharidosis type II or deficiency in iduronate-2-sulf2024
Methods to treat mucopolysaccharidosis type II or deficiency in iduronate-2-sulf2024
Analgesic and anti-addictive compositions for treatment of chronic pain and opio2024
Injection of single-stranded or self-complementary adeno-associated virus 9 into2024
AAV-ABCD1 constructs and use for treatment or prevention of adrenoleukodystrophy2023
Modified cells and methods of therapy2023
Combination for treating pain2022
Methods and compositions for treating glioma and medulloblastoma brain tumors us2022
Modified cells and methods of therapy2021